Overview

Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney

Status:
Completed
Trial end date:
2004-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine which combination of the tablets ramipril, irbesartan or spironolactone is best to lower protein leakage from the kidney.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Melbourne Health
Treatments:
Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Enzyme Inhibitors
Irbesartan
Spironolactone